CCAAT/Enhancer-binding protein β promotes pathogenesis of EAE.

Area of Science:

• Immunology
• Neuroscience
• Molecular Biology

Background:

• CCAAT/Enhancer Binding Protein β (C/EBPβ) is a transcription factor activated by inflammatory signals.
• C/EBPβ regulates genes involved in inflammation, but its role in autoimmunity is unclear.

Purpose of the Study:

• To investigate the role of C/EBPβ in the development of experimental autoimmune encephalomyelitis (EAE).
• To elucidate the mechanisms by which C/EBPβ influences autoimmune inflammation.

Main Methods:

• Experimental autoimmune encephalomyelitis (EAE) induction in wild-type and Cebpb knockout (Cebpb-/-) mice.
• Analysis of immune cell infiltration into the central nervous system (CNS).
• In vitro Th17 cell polarization and cytokine production assays.
• Chromatin immunoprecipitation (ChIP) assays to assess C/EBPβ binding to the Il23r promoter.

Main Results:

• Cebpb-/- mice were resistant to EAE induction, showing reduced immune cell infiltration into the CNS.
• Impaired Th17 cytokine production in draining lymph nodes of Cebpb-/- mice indicated defective Th17 cell priming.
• C/EBPβ was found to directly bind the Il23r gene promoter in antigen-presenting cells (APCs) and Th17 cells.
• In vitro studies suggested C/EBPβ's role in myeloid cell activation contributes to defective Th17 priming.

Conclusions:

• C/EBPβ is a key driver of autoimmune inflammation in EAE.
• C/EBPβ plays a novel role in regulating Interleukin-23 Receptor (IL-23R) expression in APCs.
• Targeting C/EBPβ may offer a therapeutic strategy for autoimmune diseases.